Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium

Seung Jin Lee; Ka Won Kang; Ji Hea Kim; Young Park; Byung Soo Kim

doi:10.1016/j.scr.2020.101913

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium

Seung Jin Lee, Ka Won Kang, Ji Hea Kim, Young Park, Byung Soo Kim

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Many patients with acute lymphoblastic leukemia (ALL) show relapse post-chemotherapy. Therefore, it is important to develop a human induced pluripotent stem cell (hiPSC) line from ALL cells to verify the pathophysiology. However, the low efficiency of the established reprogramming protocol has hampered the development of ALL hiPSC lines. Our recently reported novel reprogramming method, using human placenta-derived cell conditioned medium (hPCCM), offers a relatively higher efficiency in humanized conditions. Here, we generated an hiPSC line from ALL-derived CD34+ bone marrow cells, using hPCCM for reprogramming. This hiPSC line might be a useful model for studies on ALL.

Original language	English
Article number	101913
Journal	Stem Cell Research
Volume	47
DOIs	https://doi.org/10.1016/j.scr.2020.101913
Publication status	Published - 2020 Aug

Bibliographical note

Publisher Copyright:
© 2020 The Author(s)

ASJC Scopus subject areas

Developmental Biology
Cell Biology

Access to Document

10.1016/j.scr.2020.101913

Cite this

@article{a49996cc51b449d387c3c74506e92299,

title = "Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium",

abstract = "Many patients with acute lymphoblastic leukemia (ALL) show relapse post-chemotherapy. Therefore, it is important to develop a human induced pluripotent stem cell (hiPSC) line from ALL cells to verify the pathophysiology. However, the low efficiency of the established reprogramming protocol has hampered the development of ALL hiPSC lines. Our recently reported novel reprogramming method, using human placenta-derived cell conditioned medium (hPCCM), offers a relatively higher efficiency in humanized conditions. Here, we generated an hiPSC line from ALL-derived CD34+ bone marrow cells, using hPCCM for reprogramming. This hiPSC line might be a useful model for studies on ALL.",

author = "Lee, {Seung Jin} and Kang, {Ka Won} and Kim, {Ji Hea} and Young Park and Kim, {Byung Soo}",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s)",

year = "2020",

month = aug,

doi = "10.1016/j.scr.2020.101913",

language = "English",

volume = "47",

journal = "Stem Cell Research",

issn = "1873-5061",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium

AU - Lee, Seung Jin

AU - Kang, Ka Won

AU - Kim, Ji Hea

AU - Park, Young

AU - Kim, Byung Soo

PY - 2020/8

Y1 - 2020/8

N2 - Many patients with acute lymphoblastic leukemia (ALL) show relapse post-chemotherapy. Therefore, it is important to develop a human induced pluripotent stem cell (hiPSC) line from ALL cells to verify the pathophysiology. However, the low efficiency of the established reprogramming protocol has hampered the development of ALL hiPSC lines. Our recently reported novel reprogramming method, using human placenta-derived cell conditioned medium (hPCCM), offers a relatively higher efficiency in humanized conditions. Here, we generated an hiPSC line from ALL-derived CD34+ bone marrow cells, using hPCCM for reprogramming. This hiPSC line might be a useful model for studies on ALL.

AB - Many patients with acute lymphoblastic leukemia (ALL) show relapse post-chemotherapy. Therefore, it is important to develop a human induced pluripotent stem cell (hiPSC) line from ALL cells to verify the pathophysiology. However, the low efficiency of the established reprogramming protocol has hampered the development of ALL hiPSC lines. Our recently reported novel reprogramming method, using human placenta-derived cell conditioned medium (hPCCM), offers a relatively higher efficiency in humanized conditions. Here, we generated an hiPSC line from ALL-derived CD34+ bone marrow cells, using hPCCM for reprogramming. This hiPSC line might be a useful model for studies on ALL.

UR - http://www.scopus.com/inward/record.url?scp=85088123959&partnerID=8YFLogxK

U2 - 10.1016/j.scr.2020.101913

DO - 10.1016/j.scr.2020.101913

M3 - Article

C2 - 32707488

AN - SCOPUS:85088123959

SN - 1873-5061

VL - 47

JO - Stem Cell Research

JF - Stem Cell Research

M1 - 101913

ER -

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium

Abstract

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this